AH-TP2-26-001: Rigorous Impact Evaluation of Programs to Prevent Teen Pregnancy and Achieve Optimal Health
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Office of the Assistant Secretary for Health notices from 2026.
Office of the Assistant Secretary for Health offered grants of up to $1.3 million (at least $650,000) to nonprofits, colleges and universities, state and local governments, tribes and businesses. It expected to make about 9 awards worth $8.3 million in total. Applications closed on July 23, 2026.
From the official notice on Grants.gov, last changed October 7, 2026. Checked November 7, 2026.
- Award ceiling$1.3 million
- Award floor$650,000
- Total funding$8.3 million
- Expected awards9
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | June 23, 2026 |
|---|---|
| Deadline | July 23, 2026 |
| Archived by Grants.gov | September 1, 2026 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes and businesses.
All 14 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
U.S. Territories
Is this a realistic fit?
- Past Teenage Pregnancy Prevention Program awards averaged $2.8 million; this notice allows up to $1.3 million per award.
- Most of the program's money (70% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The Office of Population Affairs (OPA) announces the anticipated availability of funds for Fiscal Year (FY) 2026 grants under the authority of Division B, Title II of the Consolidated Appropriations Act, 2026 (Public Law 119-75).This notice solicits applications for projects to rigorously evaluate promising interventions that contribute to adolescent optimal health and preventing teen pregnancy, sexually transmitted infections (STIs), behavioral risk factors underlying teen pregnancy, or other associated risk factors. OPA intends to make available approximately $8.3 million for an estimated nine (9) grant awards for a period of up to five (5) years. The actual amount available will not be determined until enactment of the FY2027 federal budget. The goal of this initiative is to identify effective interventions focused on body literacy and ensuring transparency and protection of parental rights for future replication by adolescent health practitioners and youth-serving professionals, and to disseminate the research findings and lessons learned to inform future studies.
Who has won Teenage Pregnancy Prevention Program grants before
From fiscal 2021 to 2025, Teenage Pregnancy Prevention Program (93.297) awarded $439 million across 155 grant awards, an average of $2.8 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Education Training & Research Associates | California | 4 | $15.0 million |
| The Morehouse School of Medicine, Inc. | Georgia | 3 | $12.4 million |
| Child Trends, Incorporated | Maryland | 4 | $11.5 million |
| Policy and Research L.L.C. | Louisiana | 3 | $11.5 million |
| Fact Forward | South Carolina | 3 | $10.3 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is AH-TP2-26-001 still open?
No. It closed on July 23, 2026.
Who can apply for Rigorous Impact Evaluation of Programs to Prevent Teen Pregnancy and Achieve Optimal Health?
Office of the Assistant Secretary for Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Rigorous Impact Evaluation of Programs to Prevent Teen Pregnancy and Achieve Optimal Health?
Closed July 23, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.3 million each. About $8.3 million in total across about 9 awards.
Who has won Teenage Pregnancy Prevention Program grants before?
The largest recipients over five fiscal years were Education Training & Research Associates, The Morehouse School of Medicine, Inc., Child Trends, Incorporated. The program made 155 awards worth $439 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)